Answer
No. Its licensed role is as an add-on to ravulizumab or eculizumab; effectiveness as monotherapy has not been established.
Sources for this answer
- Voydeya 100mg film-coated tablet — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.